Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)
Clinical trial NCT03289273 · COMPLETED
Trial details
- NCT number
- NCT03289273
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-13
- Primary completion
- 2022-01-31
- Enrollment
- 1010
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.